Tsveta Milanova, Chief Commercial Officer at Agios Pharmaceuticals ($AGIO), sold shares on the open market five times over the past year for a total of $333,000. Her most recent sale occurred on March 2, 2026. These transactions rank 7,349th out of 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 4000 | $0.00 | 42,778.0000 | 74,665,003 | 10.32% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 1681 | $28.96 | 38,778.0000 | 74,665,003 | 4.15% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 5666 | $0.00 | 40,459.0000 | 74,665,003 | 16.28% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Restricted stock units | 4000 | $0.00 | 8,000.0000 | 74,665,003 | 33.33% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Restricted stock units | 5666 | $0.00 | 5,667.0000 | 74,665,003 | 50.00% | 0.01% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Stock options (right to buy) | 52000 | $0.00 | 52,000.0000 | 74,665,003 | 9999.99% | 0.07% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Restricted stock units | 14000 | $0.00 | 14,000.0000 | 74,665,003 | 9999.99% | 0.02% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 1187 | $28.96 | 41,591.0000 | 74,665,003 | 2.77% | 0.00% |
| Jan. 5, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Restricted stock units | 8475 | $0.00 | 0.0000 | 74,665,003 | 100.00% | 0.01% |
| Jan. 5, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 2872 | $27.02 | 34,793.0000 | 74,665,003 | 7.63% | 0.00% |
| Jan. 5, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 8475 | $0.00 | 37,665.0000 | 74,665,003 | 29.03% | 0.01% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Performance share units | 6000 | $0.00 | 0.0000 | 74,496,287,000 | 100.00% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 2932 | $27.09 | 29,190.0000 | 74,496,287,000 | 9.13% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 6000 | $0.00 | 32,122.0000 | 74,496,287,000 | 22.97% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 6000 | $0.00 | 28,892.0000 | 74,103,192,000 | 26.21% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 2770 | $33.54 | 26,122.0000 | 74,103,192,000 | 9.59% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Performance share units | 6000 | $0.00 | 6,000.0000 | 74,103,192,000 | 50.00% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 1681 | $35.54 | 22,892.0000 | 73,372,696,000 | 6.84% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Restricted stock units | 12000 | $0.00 | 12,000.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Stock options (right to buy) | 43500 | $0.00 | 43,500.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Restricted stock units | 5667 | $0.00 | 11,333.0000 | 73,372,696,000 | 33.34% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 5667 | $0.00 | 24,573.0000 | 73,372,696,000 | 29.97% | 0.00% |
| Jan. 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Restricted stock units | 8476 | $0.00 | 8,475.0000 | 73,372,696,000 | 50.00% | 0.00% |
| Jan. 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 8476 | $0.00 | 21,710.0000 | 73,372,696,000 | 64.05% | 0.00% |
| Jan. 6, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 2804 | $32.18 | 18,906.0000 | 73,372,696,000 | 12.92% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Stock options (right to buy) | 60000 | $0.00 | 60,000.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Restricted stock units | 17000 | $0.00 | 17,000.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 5448 | $0.00 | 14,852.0000 | 72,161,489,000 | 57.93% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Performance share units | 5448 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| Jan. 24, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 1618 | $21.64 | 13,234.0000 | 72,161,489,000 | 10.89% | 0.00% |
| Jan. 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 2902 | $22.32 | 9,404.0000 | 72,161,489,000 | 23.58% | 0.00% |
| Jan. 3, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 8475 | $0.00 | 12,306.0000 | 72,161,489,000 | 221.22% | 0.00% |
| Jan. 3, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Restricted stock units | 8475 | $0.00 | 16,951.0000 | 72,161,489,000 | 33.33% | 0.00% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Performance share units | 5449 | $0.00 | 5,448.0000 | 71,256,118 | 50.00% | 0.01% |
| June 30, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | S | Common stock | 1618 | $28.36 | 3,831.0000 | 71,256,118 | 29.69% | 0.00% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | M | Common stock | 5449 | $0.00 | 5,449.0000 | 71,256,118 | 9999.99% | 0.01% |
| Jan. 3, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Stock option (right to buy) | 135682 | $0.00 | 135,682.0000 | 71,256,118 | 9999.99% | 0.19% |
| Jan. 3, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Milanova Tsveta | Chief Commercial Officer | A | Restricted stock units | 25426 | $0.00 | 25,426.0000 | 71,256,118 | 9999.99% | 0.04% |